FLASH照射对人源肺组织的保护效应
该研究从19例接受肺叶切除术的肺癌患者获取健康肺组织,制备精密肺切片(Hu-PCLS),以9 Gy剂量在ElectronFLASH装置上分别行常规或FLASH模式体外照射。照射后24小时FLASH组分裂细胞比例更高,RNAseq显示细胞周期检查点抑制、p53促凋亡基因、DNA损伤及抗氧化通路均减弱,提示FLASH对人健康肺组织具有保护效应。
要点
- FLASH照射后24小时人肺切片分裂细胞比例高于常规照射。
- RNAseq显示FLASH后细胞周期检查点抑制与p53促凋亡基因减弱。
- FLASH后DNA损伤与抗氧化通路反应亦较常规照射减弱。
核心结论
- 在新鲜人源肺组织切片中,FLASH照射较常规照射减轻了早期细胞周期阻滞、p53促凋亡、DNA损伤及抗氧化通路反应,显示对人健康肺组织的保护效应。
研究设计与样本
- 研究纳入19例接受肺叶切除术的肺癌患者,取其健康肺组织制备精密肺切片(Hu-PCLS)。
- Hu-PCLS在体外以9 Gy剂量使用ElectronFLASH(SIT)装置分别行常规模式或FLASH模式照射。
- 照射后24小时监测细胞分裂,并行RNAseq分析探索机制。
主要发现
- 常规或超高剂量率照射后24小时,FLASH照射的Hu-PCLS中分裂细胞比例更高。
- RNAseq分析显示,与常规照射相比,超高剂量率照射后细胞周期检查点抑制减弱。
- RNAseq分析显示,与常规照射相比,超高剂量率照射后p53促凋亡基因、DNA损伤及抗氧化通路均减弱。
临床怎么用
- 细胞增殖可作为人正常肺组织对FLASH照射早期反应的标志物。
- 该结果为FLASH放疗未来临床应用的肺组织保护潜力提供了人源组织证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Radiation toxicities, such as pneumonitis and fibrosis, are major limitations affecting patients' quality of life. Developed a decade ago, FLASH radiotherapy is an innovative method that, by delivering radiation at ultrafast dose rate, reduces radiation toxicities on healthy tissue while preserving the anti-tumoral effect of radiotherapy. This so-called FLASH effect has been described in different preclinical models but has not been observed in human tissue. This study aims to determine if FLASH irradiation can induce a sparing effect on human healthy lung tissue. MATERIALS AND METHODS: To address this question, precision-cut lung slices (Hu-PCLS) were prepared from healthy lung samples collected from 19 lung cancer patients undergoing lobectomy. These Hu-PCLS were irradiated ex vivo at a dose of 9 Gy using the ElectronFLASH (SIT) device operated either in conventional or FLASH mode. We monitored cell division for each patient and performed RNAseq analysis to uncover some mechanistic insights. RESULTS: Analysis of cell division 24 h after treatment with conventional or ultra-high dose rate showed a higher proportion of dividing cells in Hu-PCLS after FLASH irradiation. Consistently, RNAseq analysis from irradiated lung samples confirmed an attenuated cell cycle checkpoint inhibition, p53 pro-apoptotic genes, DNA damage, and antioxidant pathways after ultra-high dose rate compared to conventional treatment. CONCLUSION: Altogether, this study shows that, using freshly isolated patient-derived lung samples, cell proliferation can serve as an early marker of the normal lung response to FLASH irradiation. These findings hold great promises for future applications of FLASH radiotherapy in the clinic.
引用
- Dubail M, Lafouasse C, Heinrich S, et al. Sparing effects of FLASH irradiation in patient-derived lung tissue. Radiother Oncol. 2025. PMID: 40921334. doi:10.1016/j.radonc.2025.111126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。